Biostatistical design and analysis are key elements of any clinical trial.
Establishing a sound biostatistical plan during the clinical trial design
stage will result in optimal study design and high
quality data at study completion. Comprehensive statistical input during the early stages of a
clinical development program can decrease overall costs and accelerate timelines.
In addition, well formulated statistical plans can improve the quality of all
regulatory submissions. Allphase remains current in all of the latest statistical
techniques in the literature as well as those accepted by the regulatory agencies.
Our Biostatisticians bring expertise and insight in not only study design, but
also development of complex statistical analysis plans. The experience allows
us to understand the requirements of our clients' studies and to design
statistically rigorous plans for each project. Our team has continued to
assist our clients to navigate through the complex areas of study design,
sample size determinations, stratification methods, interim analysis options,
final analysis methods, as well as data presentation, simulation, and
interpretations.
Whether you require our services as an integral part of a full clinical
development program, or as a stand alone consulting service, our
Biostatisticians, Programmers, and Consultants can make significant
contributions to your drug development needs.
|
|
|
|
|
|